Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 250 de 1066 resultados encontrados
Opções avançadas
Data de publicação: 25/11/2022 - 16:27
Researchers of the Laboratory of Entomology Diversity of the Oswaldo Cruz Institute (IOC/Fiocruz) identified a new species of stick insect in Petrópolis, in the mountainous region of the state of Rio de Janeiro. It has been named Cladomorphus petropolisensis, after the city where it was collected. The finding was published in the 10-year anniversary issue of Animals. The last species of genus Cladomorphus in the region was described in...
Notícias
Data de publicação: 25/11/2022 - 15:48
A survey by the World Health Organization (WHO) has placed Fiocruz among the world’s 15 main vaccine manufacturers. The 2022 Global Vaccine Market Report gives information on the dynamics of the vaccines market, based on the data provided by the WHO Member States. Subtitled A shared understanding for equitable access to vaccines, the report “aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more...
Notícias
Data de publicação: 22/11/2022 - 14:50
In an article published last week in the scientific journal The Lancet, experts from different countries, such as Brazil, South Africa and the United States, draw attention to the inequities faced in the COVID-19 pandemic with regard to human rights at national and global levels. In an analysis of these inequalities, pointing out differences in access to vaccination and medication, for example, the authors propose alternatives for a new story in...
Notícias
Data de publicação: 22/11/2022 - 12:43
Restrictions to the distribution of biological material placed by the legislation of countries such as India, South Africa and Brazil do not include lineages intended to be used as type lineage, i.e. material for the validation or valid publication of names of species of bacteria. This issue is the central theme of the paper entitled How legislations affect new taxonomic descriptions, published on Trends in Microbiology in November. The...
Notícias
Data de publicação: 21/11/2022 - 09:47
A scientific paper written by researchers of the BR COVID-19 Observatory, with the participation of scientists from Unesp, Fiocruz, Unicamp, UFABC and USP, presents a thorough statistical analysis to measure, in figures, the fundamental role played by mass vaccination against COVID-19 and the efficacy of this sanitary strategy implemented amidst much misinformation and hesitancy during the sanitary crisis installed in Brazil. The analysis...
Notícias
Data de publicação: 18/11/2022 - 12:36
Last Saturday (November 12) the Fiocruz Genomic Network announced the appearance of a new Omicron variant in the state of Amazonas. The variant seems to be responsible for the recent increase in the number of cases in the state. According to researcherTiago Gräf, of the Genomic Network, Amazonas has been a sentinel territory for COVID-19 monitoring. “What happens in the state tends to also happen in other regions, and it may be...
Notícias
Data de publicação: 17/11/2022 - 13:52
The Fiocruz president, Nísia Trindade Lima, and researchers Lucia Souto, Maria do Socorro de Souza and José Gomes Temporão were appointed, this Wednesday (November 16th), to the Health Technical Group in the transition team of the elected President of the Republic, Luiz Inácio Lula da Silva. The announcement was made by the vice-president-elect and coordinator of the government transition, Geraldo Alckmin, at the...
Notícias
Data de publicação: 16/11/2022 - 15:13
An article published in Nature magazine includes a list of 57 recommendations with a high degree of consensus amongst experts to end the threat to public health represented by COVID-19. The work was drawn up by a panel consisting of 386 scientists from 112 countries. Led by the Barcelona Global Health Institute (ISGlobal), the study boasts the participation of ten Brazilian scientists, of which five are from Fiocruz (Mauricio Barreto, Tania...
Notícias
Data de publicação: 08/11/2022 - 12:13
The United States Agency for International Development (USAID), the New Partnerships Initiative, Expanding Health Partnerships (NPI EXPAND), SITAWI (Finance for Good) and the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia) partnered to support the Response to COVID-19 in the Brazilian Amazon Region. The Response to COVID-19 in the Brazilian Amazon - Phase 2 is an initiative that involves civil society organizations in...
Notícias
Data de publicação: 01/11/2022 - 14:40
Boletim Internacional
Data de publicação: 31/10/2022 - 16:42
The Fiocruz Observa Infância made a survey on infant malnutrition which showed that the rates for babies below one year old have been rising in Brazil. Data show that in 2021 the Unified Health System (SUS, the Brazilian public health system) recorded an average of eight infant hospitalizations per day due to malnutrition, a consequence of nutritional deficiencies in this age group. There were a total of 2,979 hospitalizations for this age...
Notícias
Data de publicação: 31/10/2022 - 15:28
An unpublished study led by Fiocruz Amazônia evaluated the excess maternal deaths in Brazil during the first 15 months of the COVID-19 pandemic. Epidemiologist Jesem Orellana, of the Leônidas and Maria Deane Institute (ILMD/Fiocruz Amazônia), together with researchers from Brazilian, Colombian and North-American universities, showed the very worrying increase in maternal deaths in Brazil, especially during the trimester from...
Notícias
Data de publicação: 31/10/2022 - 13:51
Last Monday (24 October), Nísia Trindade Lima, president of Fiocruz, was granted the official certificate of the 2022 Brazilian Women Making a Difference Award. The award is granted by the US embassy and consulates in Brazil, as acknowledgement to relevant women all over the country. The certificate was handed to Lima by Mark Carr, cultural attaché of the United States Consulate in Rio de Janeiro, who visited the Foundation in the...
Notícias
Data de publicação: 27/10/2022 - 14:40
A study by researchers from Fiocruz and from Estácio University shows a 19% excess of deaths in 2020, the first year of the COVID-19 in the country. The group of infectious and parasitic diseases was the one that stood out the most from among the defined causes of death. The goal of the analysis was to estimate excess mortality in Brazil and in the states during that period, assuming it was different for each group of causes of death...
Notícias
Data de publicação: 21/10/2022 - 12:29
Fiocruz researchers participated, on Tuesday (Oct/18), in the 8th Global Forum of the Milan Urban Food Policy Pact (MUFPP), an event that, for the first time, took place in South America. The 2022 edition of the Forum, which was supported by Rio de Janeiro’s Local Government, had as its theme Food to Feed the Climate Justice: urban food solutions for a fairer world. For three days, more than 500 delegates from 162 cities around the world...
Notícias
Data de publicação: 19/10/2022 - 11:47
Flock (Revoada), the documentary that records the health expeditions of the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia) in the Triple Border region of the state of Amazonas, during the critical period of the COVID-19 pandemic in 2021, is one of the nominees for the Award of Latin American Independent Film Festival (Mira), which will take place in Germany from 20 to 23 October. The film will have its world premiere at...
Notícias
Data de publicação: 18/10/2022 - 14:44
At Fiocruz and around the world, the relevance of Open Access (OA) is well-known. Open Access means the free availability of scientific and technical digital content to anyone. Since 2014, the Foundation has established a Policy on Open Access to Knowledge, that refers to strengthening the mechanisms of protection and visibility of its scientific production, increasing its impact, and contributing to science development. Due to its increasing...
Notícias
Data de publicação: 13/10/2022 - 10:53
During his participation in a seminar organized by Fiocruz last Wednesday (5 October), the newly elected director of the Pan-American Health Organization (PAHO), Jarbas Barbosa, mentioned challenges in the region, such as the effects of the pandemic, the persistence of communicable diseases, the need to strengthen primary healthcare and the production of inputs, such as vaccines, in the region. The Brazilian public health physician also spoke...
Notícias
Data de publicação: 11/10/2022 - 15:31
To achieve more effective and equitable results in terms of drug policy, it must be seen from a perspective of gender and of region. Once we look at these women, we must still understand who they are, in their diversity. This was one of the points discussed at the Regional Meeting of Combined HIV Prevention and healthcare lines for women who use drugs, which took place last Monday and Tuesday (September 26 and 27) at the Fernandes Figueira...
Notícias
Data de publicação: 11/10/2022 - 15:06
Published in the Journal of Molecular Cell Biology, a Fiocruz study proves that Apixaban, an oral anticoagulant, effectively inhibits the replication of the Sars-CoV-2 virus, which causes COVID-19. This type of drug had already been recommended to prevent high levels of D-dimer, the final product of the coagulation cascade and directly related to severe COVID-19. Fiocruz researchers, however, discovered that the drug also has an antiviral...
Notícias
Data de publicação: 11/10/2022 - 10:10
The fungus that causes histoplasmosis, a disease that can affect the lungs and lead to death, was detected in Antarctica for the first time, as revealed by the study Molecular Detection of Histoplasma capsulatum in Antarctica. Written by Fioantar researchers, the paper is part of the October issue of the Emerging Infectious Diseases Journal, published by the Centers for Disease Control and Prevention (CDC) of the United States, and is one of the...
Notícias
Data de publicação: 10/10/2022 - 16:55
SpiN-TEC, a COVID-19 vaccine developed by Fiocruz Minas and by the Federal University of Minas Gerais (UFMG), can begin to be tested in humans. Last Monday (October 3), the Brazilian Health Surveillance Agency (Anvisa) authorized the beginning of the so-called clinical trials. From now on, researchers can move on to the step that evaluates the safety and the immune response generated by the vaccine. In this new phase, the immunizer will be...
Notícias
Data de publicação: 06/10/2022 - 11:07
In people who received two doses of the inactivated Coronavac vaccine, an mRNA boost offers considerably better protection against mild and severe COVID-19 than a boost with the same vaccine, according to a large observational study performed in Brazil and co-led by Fiocruz and the Barcelona Institute for Global Health (ISGlobal), an institution supported by “La Caixa” Foundation. These findings, published in Nature Communications,...
Notícias
Data de publicação: 03/10/2022 - 16:11
By means of its Center for Technological Development in Health (CDTS), Fiocruz is now part of  Repurposing of Medicines 4ALL – REMEDI4ALL, a project financed by the European Commission with the goal of supporting medicines repurposing. Initially conceived to work for five years and with a budget of 25 million euros, the platform is made up of 26 institutions from all over the world, including hospitals, research institutions,...
Notícias
Data de publicação: 28/09/2022 - 16:09
In a recent qualification course on the diagnosis of tegumentary leishmaniasis and patient care, health workers from Belize, a country in the East coast of Central America, were trained in Porto Velho. Attendants were able to follow, in practical terms, all phases of the care provided to previously scheduled patients, from reception and medical consultation at the dermatology clinic of the Rondônia Center for Tropical Medicine (Cemetron)...
Notícias

Pages

Back to the topBack